Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
- PMID: 20230549
- DOI: 10.1111/j.1524-4733.2010.00695.x
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
Abstract
Background: Health utility data often show an apparent truncation effect, where a proportion of individuals achieve the upper bound of 1. The Tobit model and censored least absolute deviations (CLAD) have both been used as analytic solutions to this apparent truncation effect. These models assume that the observed utilities are censored at 1, and hence that the true utility can be greater than 1.We aimed to examine whether the Tobit and CLAD models yielded acceptable results when this censoring assumption was not appropriate.
Methods: Using health utility (captured through EQ5D) data from a diabetes study, we conducted a simulation to compare the performance of the Tobit, CLAD, ordinary least squares (OLS), two-part and latent class estimators in terms of their bias and estimated confidence intervals. We also illustrate the performance of semiparametric and nonparametric bootstrap methods.
Results: When the true utility was conceptually bounded above at 1, the Tobit and CLAD estimators were both biased. The OLS estimator was asymptotically unbiased and, while the model-based and semiparametric bootstrap confidence intervals were too narrow, confidence intervals based on the robust standard errors or the nonparametric bootstrap were acceptable for sample sizes of 100 and larger. Two-part and latent class models also yielded unbiased estimates.
Conclusions: When the intention of the analysis is to inform an economic evaluation, and the utilities should be bounded above at 1, CLAD, and Tobit methods were biased. OLS coupled with robust standard errors or the nonparametric bootstrap is recommended as a simple and valid approach.
Similar articles
-
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4. Value Health. 2012. PMID: 23244811 Clinical Trial.
-
Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution.Med Decis Making. 2011 Nov-Dec;31(6):790-9. doi: 10.1177/0272989x11393284. Med Decis Making. 2011. PMID: 22067429
-
Predicting utility for joint health states: a general framework and a new nonparametric estimator.Med Decis Making. 2010 Sep-Oct;30(5):E29-39. doi: 10.1177/0272989X10374508. Epub 2010 Jul 19. Med Decis Making. 2010. PMID: 20643911
-
Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature.Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):753-65. doi: 10.1586/14737167.2013.850420. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 24219051 Review.
-
Bayesian extensions of the Tobit model for analyzing measures of health status.Med Decis Making. 2002 Mar-Apr;22(2):152-62. doi: 10.1177/0272989X0202200212. Med Decis Making. 2002. PMID: 11958497 Review.
Cited by
-
Impact of colonoscopy on health-related quality of life: findings from the RECEDE study.Health Qual Life Outcomes. 2024 Jun 26;22(1):49. doi: 10.1186/s12955-024-02262-x. Health Qual Life Outcomes. 2024. PMID: 38926801 Free PMC article.
-
Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.Breast Cancer. 2021 Jan;28(1):130-136. doi: 10.1007/s12282-020-01141-9. Epub 2020 Jul 25. Breast Cancer. 2021. PMID: 32712768
-
EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada.Qual Life Res. 2016 Dec;25(12):3009-3016. doi: 10.1007/s11136-016-1336-0. Epub 2016 Jun 15. Qual Life Res. 2016. PMID: 27307010
-
Effects of Diabetic Complications on Health-Related Quality of Life Impairment in Vietnamese Patients with Type 2 Diabetes.J Diabetes Res. 2020 Jan 23;2020:4360804. doi: 10.1155/2020/4360804. eCollection 2020. J Diabetes Res. 2020. PMID: 32047823 Free PMC article.
-
Short term health-related quality of life improvement during opioid agonist treatment.Drug Alcohol Depend. 2015 Dec 1;157:121-8. doi: 10.1016/j.drugalcdep.2015.10.009. Epub 2015 Oct 25. Drug Alcohol Depend. 2015. PMID: 26511766 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources